Literature DB >> 12121301

Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.

Ulrich Ebert1, Claudia Brandt, Wolfgang Löscher.   

Abstract

PURPOSE: Hippocampal sclerosis and massive neurodegeneration in other parts of the limbic system are considered hallmarks of temporal lobe epilepsy. Using the rat model of kainate-induced status epilepticus, we sought to determine if limbic sclerosis after an excitotoxic insult follows a delayed type of neurodegeneration and is thus accessible to neuroprotective intervention after the insult. Effective pharmacologic neuroprotection after status epilepticus also addresses the old question of whether degenerative morphologic changes after an epilepsy-inducing event like status epilepticus are the primary cause of epileptogenesis (i.e., the development of recurrent spontaneous seizures) during the following weeks.
METHODS: Female Wistar rats after 90 min of generalized status epilepticus were used. Molecular biologic and histologic techniques were used to demonstrate markers of delayed cell death (apoptosis) 48 h after the status. The neuroprotective effects of i.c.v. injections of caspase inhibitors and systemic injections of the anticonvulsant drugs (AEDs) dizocilpine and retigabine after the status epilepticus were studied. The effect of neuroprotective intervention on the development of recurrent spontaneous seizures was investigated by behavioral observation of the rats.
RESULTS: After generalized status epilepticus in Wistar rats, massive sclerosis of the hippocampus and the piriform cortex occurred. TUNEL labeling and electron microscopy revealed that apoptosis is involved in the degenerative processes. Immunohistochemical analysis of the time course of the expression of the proapoptotic protein Bax suggested a maximal induction of apoptosis 24-48 h after the status. Application of caspase inhibitors before or after the status did not reduce lesions, although Bax labeling was reduced. Injection of dizocilpine and to a lower extent also of retigabine after the status prevented limbic neurodegeneration and expression of markers of apoptosis. However, the neuroprotection by dizocilpine did not prevent the development of recurrent spontaneous seizures.
CONCLUSIONS: Prolonged seizure activity can induce delayed sclerosis in the hippocampus and other parts of the limbic system. This delayed cell loss can be prevented by neuroprotective drugs after a status epilepticus. However, the damage in limbic brain regions is not the main reason for limbic epileptogenesis and the occurrence of recurrent spontaneous seizures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121301     DOI: 10.1046/j.1528-1157.43.s.5.39.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Neocortical post-traumatic epileptogenesis is associated with loss of GABAergic neurons.

Authors:  Sinziana Avramescu; Dragos A Nita; Igor Timofeev
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

3.  Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo.

Authors:  Gabriela Mora; Ricardo Tapia
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

4.  Isolated seizures in rats do not cause neuronal injury.

Authors:  M T Acosta; J Munashinge; L Zhang; Daniel A Guerron; Alexander Vortmeyer; W H Theodore
Journal:  Acta Neurol Scand       Date:  2011-05-26       Impact factor: 3.209

Review 5.  Retigabine.

Authors:  Roger J Porter; Virinder Nohria; Chris Rundfeldt
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 6.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

Review 7.  Promise of resveratrol for easing status epilepticus and epilepsy.

Authors:  Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

8.  Characterization of osteopontin expression and function after status epilepticus.

Authors:  Karin Borges; Marla Gearing; Susan Rittling; Esben S Sorensen; Robert Kotloski; David T Denhardt; Raymond Dingledine
Journal:  Epilepsia       Date:  2008-06-03       Impact factor: 5.864

9.  Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model.

Authors:  Jarogniew J Luszczki; Jim Z Wu; Grzegorz Raszewski; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-05       Impact factor: 3.000

Review 10.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.